NCT07440433Not yet recruiting
Home-Based Physiotherapy in Oncology
Summary
The goal of this clinical trial is to assess the feasibility, acceptability, and safety of a supervised home-based physiotherapy programme for adult oncology patients. The programme combines aerobic cycling exercise, resistance training, and mental preparation strategies, delivered at home with regular professional supervision. The main questions this study aims to answer are: Is a 6-month supervised home-based physiotherapy programme feasible in terms of recruitment, adherence, and retention? Is the programme safe for oncology patients undergoing or having recently completed cancer treatment? Is the programme acceptable and satisfactory from the patient's perspective? How do physical function and health-related quality of life change over the course of the programme? This is a single-arm feasibility study with no comparison group. Participants will: Receive a stationary exercise bike delivered and installed at their home Follow a 6-month individualized physiotherapy programme including: Three weekly sessions combining moderate-intensity cycling and resistance exercises Wear a connected activity watch during exercise sessions to monitor heart rate and exercise duration Receive weekly supervision from oncology-trained physiotherapists through alternating in-person hospital visits and structured phone calls Complete physical function assessments and questionnaires on quality of life, fatigue, and programme satisfaction at baseline, mid-program, and study completion The results of this study will inform the design of a future larger controlled trial and contribute to the development of accessible home-based rehabilitation programmes for oncology patients.
Inclusion criteria
• Age ≥ 18 years • Diagnosis of solid cancer, undergoing or recently completed treatment. • Overall survival greater than 12 months, as judged by the treating oncologist • Clinically stable and deemed fit for moderate exercise by the treating oncologist • Able to use an exercise bike • Home environment suitable for delivery and installation of the exercise bike • Able to understand the study language and follow study instructions • Able to give a written informed consent
Exclusion criteria
• Medical contraindication to moderate exercise (e.g. uncontrolled cardiac or pulmonary disease, recent myocardial infarction, severe anemia or acute infection, unstable bone metastases or high fracture risk) • Cognitive impairment preventing active participation • Physical inability to perform the prescribed exercise programme, including cycling and resistance exercises. • Participation in another intensive rehabilitation program • Any other condition that, in the opinion of the treating oncologist or investigator, makes participation unsafe or not feasible • Pregnant or lactating women.
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Not yet recruiting
- Phase
- No phase (N/A)
- Study type
- Interventional
- Countries
- Switzerland
- Sponsor
- University Hospital, Geneva(Other)
- Protocol no.
- PRADA-HUG
- Conditions
- Rehabilitation Exercise, Oncologic Diseases
- Interventions
- Behavioral
Treatments studied
- Home-based cycling + resistance training with physiotherapist supervision
Locations · 1
- Geneva, SwitzerlandHUGNot yet recruiting at this site
In total, worldwide, the only site listed in the registry is planned; recruitment has not opened yet.
Site status per the ClinicalTrials.gov registry (last update posted: February 27, 2026).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.